Report Update Jan 1, 2025

Kazakhstan - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Kazakhstan: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Kazakhstan

In 2022, the Kazakh market for other medicaments for therapeutic or prophylactic uses decreased by X% to $X, falling for the second consecutive year after three years of growth. In general, consumption, however, recorded buoyant growth. Over the period under review, the market attained the peak level at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Kazakhstan

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X kg for the first time since 2019, thus ending a two-year declining trend. Overall, exports, however, saw a dramatic decrease. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The exports peaked at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Over the period under review, exports, however, faced a significant decline. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

Kyrgyzstan (X kg) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Kazakhstan, accounting for a approx. X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Kyrgyzstan totaled X%.

In value terms, Kyrgyzstan ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Kazakhstan.

From 2012 to 2022, the average annual growth rate of value to Kyrgyzstan stood at X%.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, growing by X% against the previous year. Over the period under review, the export price posted a notable increase. The growth pace was the most rapid in 2013 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2014 to 2022, the average export prices remained at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Kyrgyzstan.

From 2012 to 2022, the rate of growth in terms of prices for the Netherlands amounted to X% per year.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Kazakhstan

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the third consecutive year after two years of growth. Overall, imports, however, saw mild growth. The growth pace was the most rapid in 2018 when imports increased by X% against the previous year. Over the period under review, imports of hit record highs at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses fell notably to $X in 2022. Over the period under review, imports, however, showed a resilient expansion. The growth pace was the most rapid in 2018 when imports increased by X%. Imports peaked at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, France (X tons) was the main other medicaments for therapeutic or prophylactic uses supplier to Kazakhstan, with a X% share of total imports. It was followed by Russia (X tons), with a X% share of total imports. Turkey (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from France totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Russia (X% per year) and Turkey (X% per year).

In value terms, France ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Kazakhstan, comprising X% of total imports. The second position in the ranking was taken by Turkey ($X), with a X% share of total imports. It was followed by India, with a X% share.

From 2012 to 2022, the average annual growth rate of value from France amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Turkey (X% per year) and India (X% per year).

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, waning by X% against the previous year. Overall, the import price, however, enjoyed a prominent increase. The pace of growth appeared the most rapid in 2019 an increase of X%. The import price peaked at $X per ton in 2020; however, from 2021 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was India ($X per ton), while the price for Russia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Egypt (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for other medicaments for therapeutic or prophylactic uses in the world?

China remains the largest other medicaments for therapeutic or prophylactic uses consuming country worldwide, accounting for 34% of total volume. Moreover, consumption of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest consumer, India, threefold. The third position in this ranking was occupied by the United States, with an 8.1% share.

What are the largest producers of other medicaments for therapeutic or prophylactic uses in the world?

China constituted the country with the largest volume of production of other medicaments for therapeutic or prophylactic uses, accounting for 37% of total volume. Moreover, production of other medicaments for therapeutic or prophylactic uses in China exceeded the figures recorded by the second-largest producer, India, threefold. The United States ranked third in terms of total production with a 9.9% share.

What are the leading suppliers of other medicaments for therapeutic or prophylactic uses to Kazakhstan?

In value terms, France constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Kazakhstan, comprising 99% of total imports. The second position in the ranking was occupied by Russia, with a 0.7% share of total imports.

What are the leading importers of other medicaments for therapeutic or prophylactic uses from Kazakhstan?

In value terms, Russia remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Kazakhstan, comprising 64% of total exports. The second position in the ranking was occupied by the Netherlands, with a 28% share of total exports.

What is the average export price for other medicaments for therapeutic or prophylactic uses in Kazakhstan?

The average export price for other medicaments for therapeutic or prophylactic uses stood at $14,463 per ton in 2020, which is down by -23.1% against the previous year.

What is the average import price for other medicaments for therapeutic or prophylactic uses in Kazakhstan?

The average import price for other medicaments for therapeutic or prophylactic uses stood at $27,508 per ton in 2020, waning by -30.7% against the previous year.

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Kazakhstan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS

Country coverage:

Kazakhstan

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Kazakhstan
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2024
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2024
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2024
2. Market Volume, In Physical Terms, 2012–2024
3. Market Value, 2012–2024
4. Per Capita Consumption In 2012-2024
5. Imports, In Physical Terms, By Country, 2012–2024
6. Imports, In Value Terms, By Country, 2012–2024
7. Import Prices, By Country Of Origin, 2012–2024
8. Exports, In Physical Terms, By Country, 2012–2024
9. Exports, In Value Terms, By Country, 2012–2024
10. Export Prices, By Country Of Destination, 2012–2024
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2024
2. Market Value, 2012–2024
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
5. Trade Balance, In Physical Terms, 2012-2024
6. Trade Balance, In Value Terms, 2012-2024
7. Per Capita Consumption, 2012-2024
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2024
22. Production, In Value Terms, 2012–2024
23. Imports, In Physical Terms, 2012–2024
24. Imports, In Value Terms, 2012–2024
25. Imports, In Physical Terms, By Country, 2024
26. Imports, In Physical Terms, By Country, 2012–2024
27. Imports, In Value Terms, By Country, 2012–2024
28. Import Prices, By Country Of Origin, 2012–2024
29. Exports, In Physical Terms, 2012–2024
30. Exports, In Value Terms, 2012–2024
31. Exports, In Physical Terms, By Country, 2024
32. Exports, In Physical Terms, By Country, 2012–2024
33. Exports, In Value Terms, By Country, 2012–2024
34. Export Prices, By Country Of Destination, 2012–2024